🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you prof. Marc Pfeffer for your words of wisdom: “Be part of something, you cannot do it by yourself!” And that’s exactly what #PCHF has been: a 2 years course, and a life-long friendship with likeminded HFenthusiasts! #heartfailure #graduation Cardiology USZ European Society of Cardiology

Excited to announce that the inclusion of the #DECISION-trial has been completed! DECISION is the first outcome trial in 25 years to evaluate whether low-dose #digoxin is beneficial in patients with chronic #heartfailure and an impaired LVEF #umcg #groningencardiology

Interested in performing a #postdoctoral fellowship in translational #Cardiology UMCG Cardiology Research Institute? If you have a project idea complementary to our departments' research focus, please reach out! #phdlife #phd #postdoc #CardioTwitter PhD Forum …sklodowska-curie-actions.ec.europa.eu/calls/msca-pos…

4e editie van de Masterclass #hartfalen weer gestart met module 1! Samen met Mireille Emans proberen we de basis te scheppen voor een nieuwe generatie Hartfalen geïnteresseerde #cardiologen! Presentaties, hands-on workshops en klinisch redeneren in en bij het UMCG

Congratulations to Stijn for a paper that can be immediately applied in everydays cardiologist practice: @VenemaCS doi.org/10.1016/j.jaca…

Well done Janice and Hallun! rdcu.be/dADWv

"Sex differences in anatomy, physiology, pharmacokinetics, pharma-codynamics and psychosocial factors might influence the response to pharmacological agents, device therapy and cardiac rehabilitation in patients with HF." rdcu.be/dADWv

❓Weet u wat #hartfalen is? Lees meer hierover in het verhaal van Rianne: nieuws.umcg.nl/w/rianne-houdt… en kom naar ons hartfalen symposium in het UMCG 🫀 📆 24 april ⏰ 13:00-17:00 📍 Fonteinpatio #UMCG

🔥#DECISION A new #RCT on #digoxin in #HF with #LVEF < 50% both sinus rhythm & #AF Will be the last trial on the topic? Maybe with a final answer 🍀 #HFUA European Society of Cardiology Journals EJHF Editor-in-Chief Amr Abdin Henry Han Michele Emdin Gregg Fonarow MD @JJheart_doc Shelley Zieroth Kamala Tamirisa MD

#DECISION and #DIGIT_HF will inform on the relevance of digitalis glycosides in #HFrEF in patients on current #GDMT‼️ ➡️ #DIGIT_HF will report in 2025 See also our viewpoint article in #EHJ 2023 doi.org/10.1093/eurhea… David Duncker Samira Soltani Rudolf de Boer

The #DECISION trial will evaluate the efficacy of the addition of #digoxin to current HF therapies in patients with #heartfailure #HFrEF #HFmrEF, check out the design paper of this RCT: doi:10.1002/ejhf.3428

After a successful first #HFA journal club 📖 make sure you don’t miss our 2️⃣nd edition! #HFAYoung ❓Get to know more about the rapidly evolving treatment options for #HCM and discuss the ins and out of SEQOUIA-HCM 🫀 📆 October 23rd ⏰ 18:00 CEST Register now ⬇️

US trends in HF hospitalizations and HF-related mortality from 2010 to 2021 suggest that something has gone terribly wrong!

⏰ now is the time to submit your #science for #heartfailure2025 Grab your 💻 and a ☕️ and submit your #abstract before 📆 January 10th 🙋‍♀️ member of the #HFAYoung? Participate in the Young Investigator Award 🏆 and apply for a travel grant 🧳 ➡️ escardio.org/Congresses-Eve…

🌟 Abstract submissions are now OPEN for the next #HFA_ESC Congress #HeartFailure2025 ! Share your research or clinical case to gain global recognition, network with experts, and shape the future of heart failure care. 📅 Deadlines: Abstracts: 9 Jan Clinical Cases: 21 Jan

📊Analysis of 1078 pts in #STRONG_HF: 📍Rapid #GDMT uptitration (~80% dose by day 90) is safe, feasible & ⬇️#HF readmissions/mortality in pts w/wo #AFib 📍#AFib shouldn’t be a barrier, all #HF pts deserve optimal care #GDMTworks 🔗 jacc.org/doi/full/10.10… #JACCHF #Epeeps

Clinical and #Proteomic Risk Profiles of New-Onset #HeartFailure in Men and Women From the UK Biobank HF ; 📌HF incidence: 3.6/1,000 men vs. 1.72/1,000 women (P<0.001). 📌Strongest risk factors: MI in men (HR: 2.61), #AFib in women (HR: 4.10). 📌#HTN & obesity contributed

This study by Venema, Wykrzykowska et al showed that patients with aortic stenosis and features of HFpEF develop symptoms earlier and have a reduced symptomatic response, no significant decline in NT‐proBNP, and higher cardiovascular mortality after TAVI. shorturl.at/5ACPF

In ESC Heart Failure Journal: Signs of congestion have varied prognostic value. 📌 Oedema & orthopnoea = strongest links to poor QoL 📌 Elevated JVP = key predictor of 60-day HF rehospitalization 📌 Lower QoL = higher rehospitalization risk 🔗 doi.org/10.1002/ehf2.1… European Society of Cardiology

Loved the commentary of Prof. #Lund about this proof of concept study on #GeranylGeranylAcetone (GGA) in #HFpEF. Although results were neutral, we absolutely need more of these trials! I’d love to see larger cohorts & deep HFpEF phenotyping. Kudos to Dr. #Voordes & colleagues!